| Predictors of response and survival in immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma PC Lee, Y Chao, MH Chen, KH Lan, CJ Lee, IC Lee, SC Chen, MC Hou, ... Cancers 12 (1), 182, 2020 | 101 | 2020 |
| Emerging roles of epithelial-mesenchymal transition in hematological malignancies SC Chen, TT Liao, MH Yang Journal of biomedical science 25, 1-8, 2018 | 59 | 2018 |
| Rheumatoid arthritis and the risk of bipolar disorder: a nationwide population-based study CC Hsu, SC Chen, CJ Liu, T Lu, CC Shen, YW Hu, CM Yeh, PM Chen, ... PLoS One 9 (9), e107512, 2014 | 55 | 2014 |
| Secondary primary malignancy risk among patients with esophageal cancer in Taiwan: a nationwide population-based study SC Chen, CJ Teng, YW Hu, CM Yeh, MH Hung, LY Hu, FC Ku, CH Tzeng, ... PLoS One 10 (1), e0116384, 2015 | 41 | 2015 |
| Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience WC Wu, TY Lin, MH Chen, YP Hung, CA Liu, RC Lee, YH Huang, Y Chao, ... Investigational new drugs 40 (4), 789-797, 2022 | 33 | 2022 |
| Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment CT Chen, YH Feng, CJ Yen, SC Chen, YT Lin, LC Lu, CH Hsu, AL Cheng, ... Hepatology international 16 (5), 1199-1207, 2022 | 31 | 2022 |
| Second primary malignancy risk among patients with gastric cancer: a nationwide population-based study in Taiwan SC Chen, CJ Liu, YW Hu, CM Yeh, LY Hu, YP Wang, YP Hung, CH Tzeng, ... Gastric Cancer 19, 490-497, 2016 | 30 | 2016 |
| Risk of ischemic stroke in patients with gastric cancer: a nationwide population-based cohort study AS Kuan, SC Chen, CM Yeh, MH Hung, YP Hung, TJ Chen, CJ Liu Medicine 94 (37), e1336, 2015 | 27 | 2015 |
| Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching study SC Chen, YH Huang, MH Chen, YP Hung, RC Lee, YY Shao, Y Chao BMC cancer 22 (1), 55, 2022 | 20 | 2022 |
| External beam radiation therapy with or without concurrent chemotherapy for patients with unresectable locally advanced hilar cholangiocarcinoma. SC Chen, MH Chen, CP Li, PM Chang, CY Liu, CH Tzeng, YM Liu, ... Hepato-gastroenterology 62 (137), 102-107, 2015 | 20 | 2015 |
| Sick sinus syndrome associated with anti-programmed cell death-1 CY Hsu, YW Su, SC Chen Journal for ImmunoTherapy of Cancer 6, 1-5, 2018 | 18 | 2018 |
| PD‑L1 expression is associated with p16INK4A expression in non‑oropharyngeal head and neck squamous cell carcinoma SC Chen, PMH Chang, HJ Wang, SK Tai, PY Chu, MH Yang Oncology Letters 15 (2), 2259-2265, 2018 | 18 | 2018 |
| The association between prostate cancer and mood disorders: a nationwide population-based study in Taiwan PM Chen, SC Chen, CJ Liu, MH Hung, CF Tsai, YW Hu, MH Chen, ... International psychogeriatrics 27 (3), 481-490, 2015 | 18 | 2015 |
| Complete Response to the Combination of Pembrolizumab and Sorafenib for Metastatic Hepatocellular Carcinoma: A Case Report SC Chen, C Yi, MH Yang The American Journal of Gastroenterology 112 (4), 659, 2017 | 15 | 2017 |
| A single-arm phase Ib/II study of lenvatinib plus eribulin in advanced liposarcoma and leiomyosarcoma TWW Chen, CL Hsu, RL Hong, JC Lee, K Chang, CW Yu, SC Chen, ... Clinical Cancer Research 28 (23), 5058-5065, 2022 | 12 | 2022 |
| Impaired chromatin remodeling predicts better survival to modified gemcitabine and S-1 plus nivolumab in advanced biliary tract cancer: A phase II T1219 study NJ Chiang, KT Tan, LY Bai, CF Hsiao, CY Huang, YP Hung, CJ Huang, ... Clinical Cancer Research 28 (19), 4248-4257, 2022 | 12 | 2022 |
| Expression profile‑driven discovery of AURKA as a treatment target for liposarcoma CC Yen, SC Chen, GY Hung, PK Wu, WY Chua, YC Lin, CH Yen, ... International journal of oncology 55 (4), 938-948, 2019 | 12 | 2019 |
| Determinants of Survival and Post-Progression Outcomes by Sorafenib–Regorafenib Sequencing for Unresectable Hepatocellular Carcinoma IC Lee, Y Chao, PC Lee, SC Chen, CT Chi, CJ Wu, KC Wu, MC Hou, ... Cancers 14 (8), 2014, 2022 | 8 | 2022 |
| Is 1-year follow-up adequate for adult tuberculosis contacts? JY Feng, SC Chen, MC Lee, WC Fan, WJ Su, YW Hu, CM Yeh, TJ Chen, ... European Respiratory Journal 45 (5), 1501-1504, 2015 | 8 | 2015 |
| Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with FANCA mutation: a case report YH Lai, KC Tung, SC Chen Medicine 101 (39), e30719, 2022 | 6 | 2022 |
